SCHEMBL19368644

SCHEMBL19368644

C=C/C(Cl)=C\C=C(/C)CC1(N)CCN(c2ccnc3[nH]ncc23)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT2 P31751 6/20 0.55
AKT1 P31749 4/20 0.53
PIK3CD O00329 1/20 0.44
PIK3CA P42336 1/20 0.44
PIK3CB P42338 1/20 0.44
ROCK2 O75116 1/20 0.41
PRKACA P17612 1/20 0.41
PRKACG P22612 1/20 0.41
PRKACB P22694 1/20 0.41
LIMK1 P53667 1/20 0.41
LIMK2 P53671 1/20 0.41
NUDT1 P36639 4/20 0.35
GSK3B P49841 1/20 0.33
RPS6KB1 P23443 1/20 0.32
PTPN11 Q06124 3/20 0.32
TLR9 Q9NR96 1/20 0.32
TLR8 Q9NR97 1/20 0.32
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1003278 0.72 AKT2 (1.00) AKT2AKT1PIK3CDPIK3CAPIK3CB
SCHEMBL1003826 0.69 AKT2 (1.00) AKT2AKT1PIK3CDPIK3CAPIK3CB
SCHEMBL5068797 0.64 PIK3CD (0.71) AKT2AKT1PIK3CDPIK3CAPIK3CB
SCHEMBL22509304 0.64 AKT2 (0.77) AKT2AKT1PIK3CDPIK3CAPIK3CB
Hydrochloric Acid SCHEMBL3714265 0.63 PIK3CD (0.69) AKT2AKT1PIK3CDPIK3CAPIK3CB
SCHEMBL3721916 0.60 PIK3CD (0.56) AKT2AKT1PIK3CDPIK3CAPIK3CB
SCHEMBL24424256 0.60 PIK3CD (0.59) AKT2AKT1PIK3CDPIK3CAPIK3CB
SCHEMBL22509291 0.60 AKT2 (0.57) AKT2AKT1NUDT1GSK3B
SCHEMBL27491482 0.60 PIK3CD (0.59) AKT2AKT1PIK3CDPIK3CAPIK3CB
SCHEMBL21114462 0.58 AKT2 (0.44) AKT2AKT1PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2272517-B2 ORTHO -CONDENSED PYRIDINE AND PYRIMIDINE DERIVATIVES (E.G. PURINES) AS PROTEIN KINASES INHIBITORS ASTEX THERAPEUTICS LTD (GB) 2017-09-20 EP disclosed